Laurence Rodriguez
Directeur Général chez GENSIGHT BIOLOGICS S.A.
Profil
Laurence Rodriguez is currently the Chief Executive Officer & Director at Gensight Biologics SA. Previously, she worked as the Head of Rare Diseases & Rare Blood Disorders at Genzyme Therapeutics Ltd.
Ms. Rodriguez completed her undergraduate and graduate degrees at Sciences Po.
Postes actifs de Laurence Rodriguez
| Sociétés | Poste | Début |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Directeur Général | 21/12/2023 |
Anciens postes connus de Laurence Rodriguez
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Laurence Rodriguez
| Sciences Po | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |